The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, non-randomized, multi-center phase I study evaluating the safety, tolerability, pharmacokinetics and preliminary efficacy of bi-ligand-drug conjugate CBP-1018 in patients with advanced solid tumors.
 
Kaiwen Li
No Relationships to Disclose
 
Yehui Shi
No Relationships to Disclose
 
Junyan Wu
No Relationships to Disclose
 
Liyan Zhou
No Relationships to Disclose
 
Suiwen Ye
No Relationships to Disclose
 
Xiuping Lai
No Relationships to Disclose
 
Robert Huang
Employment - Coherent Biopharma
Stock and Other Ownership Interests - Coherent Biopharma
Consulting or Advisory Role - Coherent Biopharma
Research Funding - Coherent Biopharma
Patents, Royalties, Other Intellectual Property - Coherent Biopharma
Travel, Accommodations, Expenses - Coherent Biopharma
Other Relationship - Coherent Biopharma
 
Yan Teng
Employment - Coherent Biopharma
Stock and Other Ownership Interests - Coherent Biopharma
Travel, Accommodations, Expenses - Coherent Biopharma
 
Jiangang Yu
Employment - Coherent Biopharma
Travel, Accommodations, Expenses - Coherent Biopharma
 
Xiaoyan Chai
Employment - Coherent Biopharma
Travel, Accommodations, Expenses - Coherent Biopharma
 
Hai Huang
No Relationships to Disclose